Lacktman Comments on Barriers to Using Telemedicine to Treat Opioid Addiction
October 26, 2017
Politico Pro
Partner Nate Lacktman is quoted in a Politico Pro article, “Trump’s call to bolster virtual opioid treatment lacks muscle, critics say,” about ways in which the Trump administration could facilitate the use of telemedicine to treat opioid addiction.
Lacktman said it may be possible for the president to instruct the Drug Enforcement Administration to waive parts of a 2008 law that bars doctors from prescribing anti-addiction medications to patients they haven’t first seen in person. “We really need to see more from the White House on an actual rule or executive order to see what this would look like,” he said.
Lacktman said it may be possible for the president to instruct the Drug Enforcement Administration to waive parts of a 2008 law that bars doctors from prescribing anti-addiction medications to patients they haven’t first seen in person. “We really need to see more from the White House on an actual rule or executive order to see what this would look like,” he said.
People
Related News
July 24, 2025
In the News
Foley's Trial Team Featured Following Landmark Victory in Texas Trade Secret Case
Foley & Lardner LLP’s recent landmark appellate victory in a Texas trade secrets case is featured in the Texas Lawyer article, "Ruling Sets Precedent for Employment, Trade Secrets, Fiduciary Duty."
July 24, 2025
In the News
Gregory Husisian and David Simon on Tariff Evasion – 'Huge money at stake'
Foley & Lardner LLP partners Gregory Husisian and David Simon detailed the rise and risks of tariff evasion in the POLITICO article, "As Trump raises tariffs, companies find ways to cheat — and risk getting caught."
July 23, 2025
In the News
Aaron Maguregui on AI Scribes in Health Care – 'Technically, it's a third party listening'
Foley & Lardner LLP partner Aaron Maguregui shared insights on the growing applications for artificial intelligence across health care in the healthleaders article, “Is Your AI Scribe HIPAA-Compliant?“